Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer


Brausi M. A. , Oddens J. R. , Sylvester R. J. , Bono A., Van de Beek C., Van Andel G., ...More

EUROPEAN UROLOGY SUPPLEMENTS, vol.11, no.1, 2012 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 11 Issue: 1
  • Publication Date: 2012
  • Title of Journal : EUROPEAN UROLOGY SUPPLEMENTS